A phishing campaign that's gone undetected for at least six years is targeting customers of Microsoft's legacy single sign-on ...

Entrada Therapeutics (NASDAQ:TRDA) shares maintained a Buy rating and a $20.00 price target from H.C. Wainwright, well below the highest analyst target of $29.00. According to InvestingPro analysis, ...

Maryland lawmakers debate reforming medical and geriatric parole programs, considering early release for elderly and seriously ill inmates.